20/20 Biolabs, Inc. 8-K

What Happened

• 20/20 Biolabs, Inc. (AIDX) announced on May 20, 2026 that it issued a press release reporting its financial results for the quarter ended March 31, 2026. The company furnished that press release as Exhibit 99.1 to its Form 8-K under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Filing date: May 20, 2026 (Form 8-K).
• Reporting period: quarter ended March 31, 2026.
• The press release reporting the quarterly results is included as Exhibit 99.1 to the 8-K.
• The Form 8-K item cited: Item 2.02 — Results of Operations and Financial Condition.

Why It Matters

• This 8-K signals that 20/20 Biolabs has published updated quarterly earnings and operational information that investors can review to assess recent performance.
• The press release (Exhibit 99.1) will contain the specific financial figures—revenue, income or loss, and other metrics—that drive valuation and trading decisions; investors should read that release and related filings for the detailed numbers and commentary.